In order to comply with regulations and guarantee drugs’ reliability, equipment and systems qualification is essential (IQ, OQ, PQ), as they will directly or indirectly be in contact with the substances. Our engineers or experts ensure this step for our clients involved in manufacturing, packaging, storage or environmental control.

This step, which aims to demonstrate that a manufacturing or packaging process will repeatedly deliver the same product quality, is critical for drug safety. Our consultants have a good grasp of the different processes used whether for liquid, semi-liquid, solid or sterile drugs.

The drug industry uses today all kinds of softwares, apps and computer systems in its equipment and operational processes. Our consultants make sure that these IT tools comply with standards and guarantee the efficiency of operations, as expected.

Equipment, manufacturing areas and production staff must be subject to strict cleaning rules in order to avoid any risk of drug contamination. Our engineers help you set up and maintain the sanitation of your equipment and premises according to regulatory requirements.

This process oversees the transition from development to industrial batches. It identifies which parameters are critical to reproduce the same quality attributes when scaling. Our consultants carry out this phase in full awareness of production scaling issues.

Coming from the best schools in process engineering, our consultants ensure the design, acquisition and installation of equipment, premises and systems, in order to transform raw materials into therapeutic products with high added value, whatever the galenic form ( liquid, semi-solid, solid) of the drugs.

With the increasing production rates, equipment and infrastructure maintenance is essential to meet demand. Knowing that any malfunction is a potential source of financial and regulatory impacts, our consultants support our partners' maintenance projects and design appropriate solutions.

With regulatory requirements, energy efficiency and environmental in view, our consultants manage and oversee construction sites, maintenance activities or pharmaceutical buildings renovation, including the installation of ventilation, heating, electricity or plumbing systems.

Our consultants implement and manage all types of engineering projects that may occur in a pharmaceutical plant, within cost, deadlines and quality requirements. They ensure collaboration between the departments and teams concerned.

Reducing energy and raw material costs and optimizing manufacturing processes are prime targets that our consultants work to achieve, thanks to a cartographic analysis of the context, and to a logic of operational efficiency and continuous improvement.

Given how high is the electrical consumption of the equipment and installations involved, our engineers and specialists manage every electrical design or maintenance project in an energy-efficient approach and in compliance with safety and pharmaceutical GMP standards.

Necessary to the drug industry, automation consists in reducing human intervention in order to guarantee safety and increase productivity. With that in mind, our qualified consultants help our customers in their process automation projects.

Facing an increase of counterfeit medicines, effective tracking devices must make it possible to identify products and certify their originality. Our consultants assist our partners in designing and implementing their traceability system.

We support life science companies and research institutes in terms of quality assurance, which is a financial, competitive and safety issue. We take into account the quality requirements specific to our partners, along with those of the market and regulations.

The constant change of regulatory guidelines forces companies to monitor them on a daily basis. Through the expertise of our specialists, we support our clients in ensuring that their activities and products comply with the various standards in force.

We advise and help our clients monitor, evaluate, prevent and manage the risks related to their drugs' adverse effects, before and after bringing them on the market.